We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -3.85% | 1.25 | 1.10 | 1.40 | 1.30 | 1.25 | 1.30 | 284,138 | 10:30:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.57 | 1.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/3/2018 09:30 | Bob, Merck haven't 'invested' in pyc, they are a customer. | davevt | |
14/3/2018 09:15 | bobdown2 PYC is worthy of and a prime candidate for grants. That's why it wins them. The live issue here is whether the company is truly a public concern listed to return value to its shareholders or listed solely to further its research. My personal view is that its the second of the two. | pwhite73 | |
14/3/2018 08:58 | On Monday when PYC released the NON-RNS about completion of previous Innovate UK Grant the Government announced £300m of funding to go into Personalised Medicine PYC are at the centre of this so expect many more awards to come their way to look at different cancers and working with lots of different drugs and sub populations Incredible massive global potential | the stigologist | |
14/3/2018 08:57 | It's nice to see those that know nothing about Pyc handing grants over. Merck are pretty stupid as well. Maybe it's the different take by different investors. | bobdown2 | |
14/3/2018 08:56 | We saw this on November 28th 2017 after the Merck RNS You could buy all morning in the 1's Within 48 hours it was 32p heading to 50p+ before the MMs pulled a fast one The sellers can only sell once, once the shares are in strong hands people who read the news and understand it will be paying more and more to get in It's only a £3m Company at the moment but could easily be £100m+ within 12 months | the stigologist | |
14/3/2018 08:53 | Unfortunately No where nearer a solution. But keep throwing money at it. | cool hand kev | |
14/3/2018 08:53 | Stig, they don't have the 'holy Grail of personalized medicine', if you read the grant wording properly it quite clearly says they are doing DOSING AND SCHEDULE, as I've said all along, as stated on their website. They don't design drugs, it's 'personalized' dosage for each person. | davevt | |
14/3/2018 08:47 | I had one percent of this once when I got in too early and only have a small holding now. Took some losses. But Pyc had already teamed up with a European company to provide personalised medicine. Look at the cost savings for the nhs if the computer can take on some of its burden.. | bobdown2 | |
14/3/2018 08:47 | Agree stig.. Topped up a bit more but this is a medium term run for me at the moment | letmepass | |
14/3/2018 08:42 | You get it Bob but people are missing the next steps and the potential if PYC have the Holy Grail for Precision Personalised Medicine then ALL the massive Bio and Pharma companies will be beating a path to their door and offering them $$$Millions to work with them | the stigologist | |
14/3/2018 08:33 | It really is nice to see an Rns with contents that could improve the quality of life for some people. Even if it is only whilst they are receiving treatment. Forget the very shortism of the market and look at the benefits that Pyc will bring if it is succesfull. | bobdown2 | |
14/3/2018 08:31 | This is just another piece in the Jim Millen jig saw. | billthebank | |
14/3/2018 08:18 | Filtered.... | bobdown2 | |
14/3/2018 08:17 | 500k from merck covered 65% of annual cost. We the received 35k plus 70k and now 67k. | spacedust | |
14/3/2018 08:11 | It's a validation of the need for Pyc.s services in an area huge demand. Mine gives me grieve..I traveled in a car one day with three other guys in the same age group and we all had some form of problem with the prostrate. Anything that makes life easier for us older gits is to be appreciated... | bobdown2 | |
14/3/2018 08:11 | This is going worldwide folks Bio and Pharma companies will want this tech to go to the FDA with it Nobody gets it yet but Physiomics is going to be a £100m+ maybe even £1000m+ company Why do you think Dr Jim Millen ex of Glaxo Emerging Technology department decided to join a £0.5m tiddler ? | the stigologist | |
14/3/2018 08:09 | Think people who bought over 7p waiting to bail and break even | jimmyhoffa262 | |
14/3/2018 08:01 | Stig please stop it Your getting overexcited This is an actual cost to pyc | jimmyhoffa262 | |
14/3/2018 07:57 | PYC Physiomics leading the way in 'a new era of cancer care" Incredible! No wonder they are endorsed/validated by UK Government / Oxford Uni / Oxford NHS / Merck etc | the stigologist | |
14/3/2018 07:56 | Stig please stop it Your getting overexcited This is an actual cost to pyc | jimmyhoffa262 | |
14/3/2018 07:53 | See if there's a rush @ 7p and if like stig the market anticipates more soon..... | margic | |
14/3/2018 07:52 | Could well be. Blows my share price theory tomorrow. In the hands of mms and aim punters for the day! | margic |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions